Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Sees Strong Trading Volume – Time to Buy?

Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) saw unusually-strong trading volume on Monday . Approximately 159,528 shares traded hands during mid-day trading, an increase of 740% from the previous session’s volume of 18,989 shares.The stock last traded at $22.86 and had previously closed at $19.50.

Wall Street Analysts Forecast Growth

TLX has been the topic of several research reports. William Blair upgraded shares of Telix Pharmaceuticals Limited American Depositary Shares to a “strong-buy” rating in a research report on Tuesday, November 19th. UBS Group lifted their target price on shares of Telix Pharmaceuticals Limited American Depositary Shares from $21.00 to $22.00 and gave the stock a “buy” rating in a research note on Monday, January 27th.

Telix Pharmaceuticals Limited American Depositary Shares Trading Down 1.5 %

The business’s 50-day simple moving average is $16.91.

Telix Pharmaceuticals Limited American Depositary Shares Company Profile

Telix Pharmaceuticals Ltd. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals.